George Demetri

Insider Reports History

Entity
Individual
Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA
Signature
/s/ Ariel Hurley, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Demetri:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Common Stock 8.41K $757K $90.00 Jun 21, 2022 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 5.3K Jun 21, 2022 Direct
Translate Bio, Inc. Director Stock Option (right to buy) 0 Sep 14, 2021 Direct

Insider Reports Filed by George Demetri

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jun 21, 2022 4 $241 4 Jun 30, 2022 Director
TBIO Translate Bio, Inc. Sep 14, 2021 3 $0 4 Sep 14, 2021 Director
TBIO Translate Bio, Inc. Sep 14, 2021 3 $0 4 Sep 14, 2021 Director
TBIO Translate Bio, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director